Evidence map›Paper›PMID 29868373›Full record

ArticlePreventive medicine reports2018

Diabetes diagnosis and management among insured adults across metropolitan areas in the U.S.

Wenya Yang, Timothy M Dall, Eleonora Tan, Erin Byrne, William Iacobucci, Ritashree Chakrabarti, F Ellen Loh

Abstract read
In one paragraph

Article in Preventive medicine reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Wenya YangThe Lewin Group, 3130 Fairview Park Drive, Suite 500, Falls Church, VA 22042, USA.
Timothy M DallIHS Markit, 1300 Connecticut Ave., NW, Suite 401, Washington, DC 20036, USA.
Eleonora TanThe Lewin Group, 3130 Fairview Park Drive, Suite 500, Falls Church, VA 22042, USA.
Erin ByrneNovo Nordisk Inc., 800 Scudders Mill Road, Plainsboro, NJ 08536, USA.
William IacobucciIHS Markit, 1300 Connecticut Ave., NW, Suite 401, Washington, DC 20036, USA.
Ritashree ChakrabartiIHS Markit, 1300 Connecticut Ave., NW, Suite 401, Washington, DC 20036, USA.
F Ellen LohThe Peter Lamy Center on Drug Therapy and Aging, Department of Pharmaceutical Health Services Research, University of Maryland Baltimore, 220 Arch St, Room 12-212, Baltimore, MD 21201, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study provides diabetes-related metrics for the 50 largest metropolitan areas in the U.S. in 2012-including prevalence of diagnosed and undiagnosed diabetes, insurance status of the population with diabetes, diabetes medication use, and prevalence of poorly controlled diabetes. Diabetes prevalence estimates were calculated using cross-sectional data combining the Behavioral Risk Factor Surveillance System, American Community Survey, National Nursing Home Survey, Census population files, and National Health and Nutrition Examination Survey. Analysis of medical claims files (2012 de-identified Normative Health Information database, 2011 Medicare Standard Analytical Files, and 2008 Medicaid Analytic eXtract) produced information on treatment and poorly controlled diabetes by geographic location, insurance type, sex, and age group. Among insured adults with diagnosed type 2 diabetes in 2012, the proportion receiving diabetes medications ranged from 83% in Oklahoma City, Oklahoma, to 65% in West Palm Beach, Florida. The proportion of treated patients with medical claims indicating poorly controlled diabetes was lowest in Minneapolis, Minnesota (36%) and highest in Texas metropolitan areas of Austin (51%), San Antonio (51%), and Houston (50%). Estimates of diabetes detection and management across metropolitan areas often differ from state and national estimates. Local metrics of diabetes management can be helpful for tracking improvements in communities over time.

Indexed as

DiabetesManagement

Identifiers

PMID29868373
PMCPMC5984223

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.